Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • wacguy
    Member
    • Sep 2012
    • 24

    Epicentre kit & Bioanalyzer result

    Hi there,

    I start constructing RNA-seq libraries after a few month of planning it, from Arabidopsis root material. My initial sample size is very low but using RNAzol, I can get total of 10-15ng high quoality RNA in 10microliter. I decided to try and make a stranded library using the Epicemtre Ribo-zero (for leaf, it is their best kit now and was recommended by their rep) followed by the ScriptSeq v2 RNA-Seq Library Preparation Kit (although the RZ requires 100ng and I had ~10). I was following the protocol (including the AmpureXP) and made 18 PCR cycle as a last step (using index # 1 reverse primer) and surprisingly got a nice library. It looks good on a gel, could amplify 3 genes by PCR but I want some opinions about the bioanalyzer (attached) result: first curve is my library and the second is a colleague + control. Specifically, what are 2 picks around 46 bp (primer dimer) and why do I have the shoulder of long fragments. Last, the index primers kit mentions that each primer (reverse) is 64 bases, seems very long to me.

    Thanks a lot,
    Guy
  • CHHALD
    Junior Member
    • Aug 2013
    • 2

    #2
    Dear Guy

    I can see from your post that you tried the Scriptseq v2 kit using 10 ng total RNA as input. I have the same problem as you with low levels of starting material, although I have about 30 ng per sample.

    I am hoping that you could let me know if you ended up using the Scriptseq v2 kit, and if you were happy with your results.

    Best,
    Christa

    Comment

    • wacguy
      Member
      • Sep 2012
      • 24

      #3
      Hi Christa,

      Yes, I was using it and it all works well (for the Ribo-zero, I use half of the amounts as one of their reps suggested me, and it also saves money). I succefuly ran the Toxedo package and could identify many interesting things, the only problem is that I had very low mapability, which I still don't know the reason for.

      Let me know if uoi have any more questions,
      Guy

      Comment

      • CHHALD
        Junior Member
        • Aug 2013
        • 2

        #4
        Dear Guy

        Thank you for the quick answer! I will go on to try it myself!

        Best,
        Christa

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          07-20-2026, 11:48 AM
        • SEQadmin2
          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by SEQadmin2



          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
          ...
          07-09-2026, 11:10 AM
        • SEQadmin2
          Cancer Drug Resistance: The Lingering Barrier to Rising Survival
          by SEQadmin2



          Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

          There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
          07-08-2026, 05:17 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 07-24-2026, 12:17 PM
        0 responses
        21 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-23-2026, 11:41 AM
        0 responses
        19 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-20-2026, 11:10 AM
        0 responses
        26 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-13-2026, 10:26 AM
        0 responses
        38 views
        0 reactions
        Last Post SEQadmin2  
        Working...